Compare HALO & CSGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | CSGP |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 12.9B |
| IPO Year | 2001 | 1998 |
| Metric | HALO | CSGP |
|---|---|---|
| Price | $125.99 | $34.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 21 |
| Target Price | ★ $108.78 | $37.40 |
| AVG Volume (30 Days) | 2.2M | ★ 4.9M |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.11 | 0.14 |
| Revenue | $151,862,000.00 | ★ $965,230,000.00 |
| Revenue This Year | $34.69 | $16.65 |
| Revenue Next Year | $11.65 | $11.16 |
| P/E Ratio | ★ $39.88 | $251.46 |
| Revenue Growth | N/A | ★ 15.23 |
| 52 Week Low | $61.23 | $25.89 |
| 52 Week High | $125.43 | $79.07 |
| Indicator | HALO | CSGP |
|---|---|---|
| Relative Strength Index (RSI) | 74.21 | 66.95 |
| Support Level | $105.27 | $33.32 |
| Resistance Level | N/A | $34.84 |
| Average True Range (ATR) | 3.51 | 1.14 |
| MACD | 1.11 | 0.67 |
| Stochastic Oscillator | 99.04 | 83.39 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
CoStar Group is a global provider of proprietary information, analytics, and online marketplaces serving both commercial and residential real estate. The firm operates through a diverse portfolio of brands, including CoStar Suite for commercial real estate research, LoopNet for commercial listings, Apartments.com for multifamily rentals, and Homes.com for residential brokerage. It primarily sells high-margin software-as-a-service subscriptions that provide institutional clients with forensic property data and premium advertising visibility. With operations across North America, Europe, and Asia-Pacific, CoStar maintains the industry's most comprehensive centralized real estate database, functioning as a critical information utility for brokers, lenders, and owners worldwide.